Blood Counts During Chemotherapy: Nadir and What Your CBC Means
Chemotherapy damages the fast-dividing cells in your bone marrow along with the cancer, so the three cell lines it produces — white cells, red cells and platelets — all fall after treatment and then recover. The lowest point is called the nadir, and for most regimens it arrives 7 to 14 days after each dose, with recovery by day 21 to 28. This page explains when each line bottoms out, what the numbers on your complete blood count actually mean, and the thresholds that decide whether your next cycle goes ahead on time.
Key Numbers
- Nadir timing: usually days 7–14 after chemotherapy
- Recovery: usually days 21–28, which is why cycles are three or four weeks apart
- Normal ANC: 1,500–8,000/µL; below 500/µL is severe neutropenia
- ANC needed to proceed with treatment: typically at least 1,000–1,500/µL
- Platelets needed to proceed: typically at least 75,000–100,000/µL
- Fever of 100.4°F / 38°C at any count: emergency, regardless of what the last blood test showed
The Nadir: When Counts Are Lowest
Bone marrow stem cells are among the fastest-dividing cells in the body, which is why chemotherapy hits them. The fall is not immediate, because the cells already circulating in the bloodstream have to live out their normal lifespan first. That lifespan is what determines when each line bottoms out.
Typical Timeline After a Dose
- Days 1–5: Counts often still normal. Marrow production has stopped, but circulating cells have not yet been used up.
- Days 7–14: The white cell nadir. Neutrophils circulate for only 6 to 12 hours once they leave the marrow, so they fall first and fastest. This is the window of highest infection risk.
- Days 8–14: The platelet nadir, usually just after or alongside the white cell nadir. Platelets live 7 to 10 days.
- Days 21–28: White cells and platelets recover. This is why cycles are spaced as they are — the interval exists to let the marrow catch up.
- Cumulative, over cycles: Red cells last around 120 days, so haemoglobin does not have a sharp nadir. It drifts downward across cycles and is usually lowest late in the course.
Nadir timing varies by drug. Most standard regimens follow the pattern above. Some agents are notably different: the nitrosoureas such as carmustine and lomustine cause a delayed nadir at four to six weeks, and mitomycin C behaves similarly, which is why these drugs are given less frequently. Weekly regimens like weekly paclitaxel produce shallower dips that do not fully recover between doses. Ask which pattern applies to your regimen — it tells you which days to be most careful.
The nadir is a guide, not a guarantee. A fever on day 3 or day 19 is exactly as urgent as one on day 10. If your temperature reaches 100.4°F (38°C), or you get shaking chills, go in — see when to call your oncology team. Counts can also be normal at the moment infection begins, which is why a normal blood test never rules it out.
Reading Your CBC Report
Most patients are handed the same printout every cycle and never told which lines matter. These are the ones your team is looking at.
| Line | What it measures | Typical normal range |
|---|---|---|
| WBC | Total white blood cells, all types combined | 4,000–11,000/µL |
| ANC | Absolute neutrophil count — the infection-fighting subset. The number that actually matters. | 1,500–8,000/µL |
| Hgb | Haemoglobin — oxygen-carrying capacity | 12–16 g/dL (women), 13.5–17.5 g/dL (men) |
| Hct | Haematocrit — proportion of blood volume that is red cells; tracks haemoglobin | 36–46% (women), 40–52% (men) |
| PLT | Platelets — clotting | 150,000–400,000/µL |
| MCV | Average red cell size — helps distinguish iron deficiency from B12 or folate deficiency | 80–100 fL |
| ANC calculation | ANC = WBC × (% neutrophils + % bands) ÷ 100. A WBC of 3,000 with 50% neutrophils and 5% bands gives an ANC of 1,650/µL. | |
Why WBC Alone Can Mislead
The total white count includes lymphocytes and monocytes, which do not protect against bacterial infection in the same way. A patient can have a reassuring WBC of 4,000 made up largely of lymphocytes while the ANC sits at 600 — severely neutropenic. If only one number is quoted to you, ask for the ANC.
White Cells and ANC
| ANC | Grade | What it means practically |
|---|---|---|
| ≥ 1,500/µL | Normal | Standard precautions. Infection risk is not meaningfully raised. |
| 1,000–1,499/µL | Mild neutropenia | Slight increase in risk. Treatment usually proceeds. |
| 500–999/µL | Moderate | Meaningful risk. Avoid crowds and anyone unwell; treatment often delayed. |
| < 500/µL | Severe | High risk of serious infection. Any fever is a medical emergency. |
| < 100/µL | Profound | Very high risk; some patients receive prophylactic antibiotics. |
Because neutrophils are what produce the visible signs of infection, a severely neutropenic patient may have a serious infection with no redness, no swelling and no pus — only a fever. This is the reason the fever threshold is so low and so absolute. Our neutropenia guide covers infection prevention and food safety in more detail, and infection risk during treatment covers day-to-day precautions.
Red Cells and Haemoglobin
Chemotherapy-related anaemia builds gradually rather than dipping and recovering, because red cells survive around four months. Many patients feel steadily more tired through a course of treatment without realising that the cause is measurable and often treatable.
Hgb 10–12 g/dL
Mild. Often noticed only as reduced stamina. No specific treatment; iron studies worth checking.
Hgb 8–10 g/dL
Moderate. Breathlessness on stairs, palpitations, feeling cold, poor concentration. Cause is investigated — iron, B12, folate, bleeding, kidney function.
Hgb below 8 g/dL
Severe. Transfusion is commonly considered, particularly with symptoms or cardiac disease.
What severe anaemia actually feels like is worth describing plainly, because it is often mistaken for depression or simple deconditioning: heaviness in the legs after a few steps, a heart that pounds after minor effort, dizziness on standing, persistent cold hands and feet, headache, unusual pallor in the palms and inner eyelids, and a level of fatigue that sleep does not touch. Some people also develop unusual cravings, such as for ice. If this is your experience, it is worth asking for a haemoglobin check rather than assuming it is an unavoidable part of treatment. See our anaemia guide and cancer-related fatigue.
Platelets
| Platelet count | What it means |
|---|---|
| ≥ 150,000/µL | Normal. |
| 75,000–149,000/µL | Mild. Bruising more easily. Treatment usually proceeds. |
| 50,000–74,000/µL | Moderate. Avoid contact sports, razors and aspirin or ibuprofen unless prescribed. Treatment often delayed. |
| 20,000–49,000/µL | Significant. Bleeding gums and nosebleeds common. Precautions tightened; dental work and procedures postponed. |
| < 20,000/µL | Severe. Risk of spontaneous bleeding; transfusion often given. |
Report bleeding that does not stop after ten minutes of pressure, blood in urine or stool, black tarry stool, a sudden crop of tiny red spots on the skin (petechiae), a nosebleed lasting more than 15 minutes, or any head injury while platelets are low. Avoid aspirin and NSAIDs unless your team has specifically approved them.
Thresholds for Proceeding with Treatment
Before each cycle your counts are checked, and the decision to proceed, delay or reduce the dose is made on those numbers. Exact thresholds vary by regimen and by intent — curative treatment is pushed harder than palliative — but these are the values used most commonly:
- ANC of 1,000–1,500/µL or above is generally required to give the next dose. Many regimens use 1,500; some use 1,000.
- Platelets of 75,000–100,000/µL or above are generally required.
- Haemoglobin rarely delays treatment on its own, since it is correctable with transfusion.
If counts have not recovered, the usual response is a delay of a week and a repeat test. Repeated delays, or a delay combined with a previous episode of febrile neutropenia, typically lead to either a dose reduction of 20–25% or the addition of a growth factor to the next cycle. A delay is not a setback in the sense patients often fear — it is the system working as designed, and giving a full dose into an unrecovered marrow causes more harm than waiting a week.
Growth Factors and Why They Sometimes Fail
Granulocyte colony-stimulating factors — filgrastim (Neupogen) and pegfilgrastim (Neulasta) — push the marrow to produce neutrophils faster, shortening the neutropenic window rather than preventing the dip entirely. They are used when a regimen carries a high risk of febrile neutropenia, or after an episode has already occurred.
What Normal Response Looks Like
- Filgrastim is usually started 24 to 72 hours after chemotherapy and continued daily for several days; pegfilgrastim is a single injection per cycle.
- A transient spike in white count in the first day or two is expected and is not a sign of infection.
- Bone pain in the lower back, pelvis, sternum and long bones is the most common side effect, caused by the marrow expanding. It usually responds to paracetamol or an antihistamine such as loratadine.
- The count then falls before rising again as the marrow recovers — a dip after starting the injections is expected, not a failure.
When Counts Do Not Rise
If white cells stay low despite growth factor support, several explanations are worth raising with your team:
- Timing. Blood drawn during the expected trough, or too soon after starting, will not yet show the rise.
- Cumulative marrow damage. After many cycles, or after prior radiotherapy to marrow-rich bones such as the pelvis and spine, the marrow reserve is genuinely reduced and responds more slowly.
- Ongoing infection. An active infection consumes neutrophils as fast as they are produced.
- Nutritional deficiency. B12, folate or copper deficiency limits production regardless of stimulation.
- Other medicines. Some antibiotics, antivirals and antifungals suppress the marrow independently.
- Marrow involvement by disease. Extensive bone marrow infiltration limits what any growth factor can achieve.
- Administration. Storage and injection technique matter; these are refrigerated biologics that lose potency if mishandled.
Growth factors do not fix low haemoglobin or low platelets. Anaemia is managed with iron, transfusion or occasionally erythropoiesis-stimulating agents, and low platelets are managed with dose adjustment and transfusion.
Frequently Asked Questions
When is the lowest white cell count after chemo?
Usually 7 to 14 days after each dose, with recovery by day 21 to 28. Nitrosoureas such as carmustine and lomustine are the main exception, with a delayed nadir at four to six weeks. Ask your team which days apply to your specific regimen.
What is the lowest neutrophil count that still allows chemo to go ahead?
Most regimens require an ANC of at least 1,000 to 1,500/µL, and platelets of at least 75,000 to 100,000/µL. Below those, treatment is normally delayed a week and repeated. Thresholds differ by protocol and by whether treatment is curative or palliative, so your unit's number is the one that counts.
Can chemotherapy be given with a low white cell count?
Sometimes, with a reduced dose or with growth factor support, particularly when the treatment is curative in intent and the count is only mildly low. It is a considered decision balancing infection risk against maintaining dose intensity, not a fixed rule.
Why is my white count normal when I clearly have an infection?
Timing and composition. An infection may begin before the nadir, and a stress response can push immature cells into the blood, propping up the total WBC while functional neutrophils remain low. A normal count does not rule out infection during chemotherapy, and it is never a reason to stay home with a fever.
Does a low blood count mean the chemotherapy is working?
No. The degree of marrow suppression reflects how the drug affects normal dividing cells, not how well it is killing cancer. Response is assessed with imaging and tumour markers. Equally, counts that stay near-normal do not mean the treatment is failing.
How long after treatment ends do counts return to normal?
White cells and platelets usually recover within three to four weeks of the last dose. Haemoglobin takes longer — often two to three months — because red cells are replaced slowly. Lymphocyte counts can stay below normal for six to twelve months, and longer after some regimens, which is why vaccination timing is planned with your team.
Related Resources
Medical Disclaimer: Reference ranges and treatment thresholds vary between laboratories and protocols. Use this page to understand your results, not to make decisions about your treatment. Always interpret your counts with your own oncology team.